AGPS and hepatocellular carcinoma: Evidence from molecular epidemiological studies has proved low detoxification capacity resulting from abnormal expression of detoxicating enzyme genes were positively correlated with the levels of ADAs in the peripheral blood or cancerous tissues with HCC [27, 28].